Envisioning a Transformed Clinical Trials Enterprise in the United States Establishing an Agenda for 2020: Workshop Summary (2012) / Chapter Skim
Currently Skimming:
Appendix C: Registered Workshop Attendees
Appendix C: Registered Workshop Attendees
Pages 123-132
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 123... ...
J Brooks Health Science Administrator Stefano Bertuzzi Director, Office of Science Policy, Office of Rare Diseases Research Planning and Communications National Institutes of Health National Institutes of Mental Health 123
|
From page 124... ...
124 ENVISIONING A TRANSFORMED CLINICAL TRIALS ENTERPRISE Steven Brotman Christine Carter Senior Vice President, Payment Vice President, Scientific Affairs and Health Care Delivery Society for Women's Health Policy Research AdvaMed Dorothy Castille National Institute on Minority Suanna Bruinooge Director, Research Policy Health and Health Disparities American Society of Clinical National Institutes of Health Oncology Carroll Child Clinical Research Risk Manager Barbara Buch U.S. Food and Drug University of California, San Administration Francisco Liza Bundesen Charles Clayton Acting Chief, Science Policy and Director of Training Evaluation Branch American Society of Hematology Office of Science Policy, Planning, and Communications Elaine Collier National Institute of Mental Senior Advisor to Director Health National Center for Research Resources National Institutes of Health Robert Califf Director, Duke Translational Medicine Institute Doug Cropper Vice Chancellor for Clinical and President and Chief Executive Translational Research Officer Professor of Medicine Genesis Health System Duke University Medical Center Dennis Cryer Chief Medical Officer Scott Campbell Executive Director & CEO CryerHealth Foundation for the National Institutes of Health Donna Cryer CEO CryerHealth Tanisha Carino Senior Vice President Avalere Health Ulyana Desiderio Senior Manager for Scientific Affairs Kelli Carrington Lead, Public Affairs American Society of Hematology National Institutes of Health Clinical Center
|
From page 125... ...
Regulatory Affairs and Safety Amgen Inc. Jenny Gaffney Senior Manager Avalere Health Lynn Etheredge Consultant, Rapid Learning Project Elaine Gallin George Washington University Principal QE Philanthropic Advisors Gary Filerman President John Gallin Atlas Health Foundation Director, Clinical Center National Institutes of Health Louis Fiore Principal Investigator, VA Annetine Gelijns Cooperative Studies Program Professor of Health Policy Director, VA Cooperative Studies Co-Chair, Department of Health Program Coordinating Center, Evidence and Policy Boston Mount Sinai School of Medicine Department of Veterans Affairs
|
From page 126... ...
Candice Griffin Senior Program Manager John Iglehart American Society of Clinical National Correspondent Oncology New England Journal of Medicine Claudia Grossmann Rebecca Jackson Program Officer Professor and Associate Dean for Institute of Medicine Clinical Research Director and Principal Investigator, OSU Center for Kristi Guillory Senior Policy Analyst Clinical and Translational American Cancer Society Science The Ohio State University
|
From page 127... ...
National Institutes of Health Hon-Sum Ko David Leventhal Medical Officer Director, Clinical Innovation Center for Drug Evaluation and Pfizer Inc. Research U.S.
|
From page 128... ...
Food and Drug Administration National Cancer Policy Forum Institute of Medicine Karen Margolis Professor of Medicine, University Richard Murray of Minnesota Medical School Vice President, Global Center for Director of Clinical Research Scientific Affairs HealthPartners Research Office of the Chief Medical Foundation Officer Merck & Co., Inc. Paula McKeever Senior Policy Coordinator Elizabeth Ness Center for Drug Evaluation and Nurse Consultant Research National Cancer Institute U.S.
|
From page 129... ...
Komen for the Cure Gary Persinger Theodore Reiss Consultant Research Professor of Medicine National Pharmaceutical Council Vanderbilt
|
From page 130... ...
130 ENVISIONING A TRANSFORMED CLINICAL TRIALS ENTERPRISE John Reppas Deborah Runkle Director of Public Policy Senior Program Associate Neurotechnology Industry American Association for the Organization Advancement of Science Gloria Romanelli Jody Sachs Senior Director Program Officer American College of Radiology National Center for Research Resources National Institutes of Health Patrick Rooney Co-Founder Bionymity, Inc. Chas Scammell Director, New York Pharmaceutical Practice Jean Rouleau Scientific Director, Institute of Milliman Circulatory and Respiratory Health Amber Hartman Scholz Canadian Institutes of Health Assistant Executive Director Research President's Council of Advisors on Science and Technology & Office of Science and Arthur Rubenstein Professor, Department of Technology Policy Medicine, Division of Endocrinology Jeff Schomisch Raymond and Ruth Perelman Senior Managing Editor School of Medicine Guide to Good Clinical Practice University of Pennsylvania Kevin Schulman Professor of Medicine and Emily Rubinstein Manager, Data Analytics Gregory Mario and Jeremy Context Matters Mario Professor of Business Administration Duke University School of Richard Rudick Hazel Prior Hostetler Chair of Medicine and the Fuqua School Neurology, Cleveland Clinic of Business Professor of Medicine, Cleveland Clinic Lerner College of Talisha Searcy Medicine Program Analyst Case Western Reserve University Office of Inspector General, Office of Evaluation and Inspections U.S.
|
From page 131... ...
Food and Drug Administration Indian Health Service Janet Tobias President Sierra/Tango Heather Snyder Senior Associate Director, Productions Scientific Grants Ikana Media Alzheimer's Association Sean Tunis President & CEO Anil Srivastava Director Center for Medical Technology Open Health Systems Laboratory Policy Scott Steele Kathleen Uhl Director, Research Alliances Deputy Director, Office of University of Rochester Medical Policy Center for Drug Evaluation and Research U.S. Food and Drug Administration
|
From page 132... ...
132 ENVISIONING A TRANSFORMED CLINICAL TRIALS ENTERPRISE Clyde Yancy Jill Wechsler Magerstadt Professor of Washington Editor Medicine, Chief, Division of Pharmaceutical Executive magazine Cardiology Feinberg School of Medicine, Neil Weisfeld Northwestern University New Associates, LLC Tara Yazinski Neil Weissman Advocate President National Fibromyalgia and MedStar Health Research Chronic Pain Association Institute John Yeh Clarissa Wittenberg Professor Consultant Massachusetts General Hospital, European Organization for Harvard Research and Treatment of Cancer Peter Yu Oncologist, Palo Alto Medical Hui-Hsing Wong Foundation Medical Officer Chair, Electronic Health Record Assistant Secretary for Planning Working Group and Evaluation American Society of Clinical U.S. Department of Health and Oncology Human Services Deborah Zarin Alastair Wood Director, ClinicalTrials.gov Partner & Managing Director National Library of Medicine Symphony Capital LLC Paul Zimmet Janet Woodcock Research Advocate Director Parkinson's Disease Foundation Center for Drug Evaluation and Research Bram Zuckerman U.S.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.